Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam for Intraoperative Movement in UIA Clipping
NCT05553678Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of midazolam in brain aneurysm (IA) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Intraoperative movement. Status: unknown.
02
Drugs
midazolam
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on NCT05553678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05553678.